期刊文献+

β_2受体激动剂对哮喘豚鼠糖皮质激素受体功能影响的研究 被引量:1

Experimental studies on the effects of β_2 adrenoceptor agonists on the roles of glucocorticoids in asthmatic management
下载PDF
导出
摘要 目的 探索 β2 受体激动剂 (β2 AA)对哮喘豚鼠血淋巴细胞糖皮质激素受体 (GR)功能的影响。方法 采用放射性配基结合分析法测定哮喘豚鼠血淋巴细胞GR的Kd 及Bmax,用凝胶阻滞分析法测定GR与糖皮质类固醇反应片段(GRE)的结合能力。结果 各组淋巴细胞GR的Kd 无明显差异 (P >0 0 5 ) ;沙丁胺醇组淋巴细胞GR的Bmax与对照组比较无明显差异 (P >0 0 5 ) ,沙丁胺醇组GR与GRE结合值〔(1 5± 0 4)RDU〕与对照组〔(8 7± 2 4)RDU〕比较差异有显著性 (P <0 0 1) ,地塞米松组GR与GRE组合值〔(15 9± 3 2 )RDU〕与对照组比较差异有显著性 (P <0 0 1) ,沙丁胺醇加地塞米松组 (7d ,14d)GR与GRE结合值〔(4 9±2 1)RDU ,(2 2± 0 8)RDU〕与对照组比较差异有显著性(P <0 0 1) ,且遂渐下降 ,具有时间依赖性。结论 β2 AA可降低GR与GRE的结合能力 ,削弱糖皮质激素的作用 ,长期应用 β2 AIM To study the effects of β 2 adrenoceptor agonists (β 2AA) on the functions of glucocorticoid receptor(GR) in blood lymphocytes of asthmatic guinea pigs. METHODS Measuring K d(affinity)and B max (maximum binding capacity) of GR by radioligand binding assay of receptors(RBA) and the binding of glucocorticoid receptors(GR) and glucocorticoid response elements(GRE) by electrophoretic mobility shift assay(EMSA) in blood lymphocytes of asthmatic guinea pigs. RESULTS The band density of GR and GRE binding in the salbutamol group〔(1 5±0 4) RDU〕 was lower than that〔(8 7±2 4) RDU〕 in the control( P <0 01), and the band density of GR and GRE binding in the dexamethasone〔(15 9±3 2) RDU〕 was higher than that in control( P <0 01). The band desity of GR and GRE binding in the salbutamol+dexamethasone groups〔7 days,14 days,(4 9±2 1) RDU,(2 2±0 8) RDU〕 was respectively lower than that in the control and decreased gradually in a time dependent manner. CONCLUSION β 2AA might decrease the ability of GR and GRE binding and inhibit the anti inflammatory effects of glucocorticoids. It is not suitable for using β 2AA to control asthma in a long term.
出处 《中国药理学通报》 CAS CSCD 北大核心 2001年第3期316-318,共3页 Chinese Pharmacological Bulletin
关键词 哮喘 受体激动剂 糖皮质激素 asthma β adrenoceptor agonist glucocorticoid
  • 相关文献

参考文献1

二级参考文献1

  • 1吕定璋,中华医学杂志,1987年,67卷,313页

共引文献48

同被引文献12

  • 1Shrewsbury SB, Pyke SD, Britton M. A meta-analysis of increasing inhaled steroid or adding salmeterol in symptomatic asthma[J].Br Med J,2000,320(15):1368-1373.
  • 2Bateman ED, Britton M, Carrillo J. Salmeterol/fluticasone(50/100 μg) combination inhaler a new, effective and well tolerated treatment for asthma[J].Clin Drug Invest,1998,16(3):193-201.
  • 3Based on the workshop report.global strategy for asthma management and prevention revised[R].2002.2-3.
  • 4Adami GS,Agostini NMC.Immune mechanisms in interstitial lung diseases[J].Alleray,2000,55(9):1103-1120.
  • 5Meltzer EO.Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of one linked air way disease[J].Ann Allergy Asthma Immunol,2000,84(11):176-187.
  • 6Oyamada H, Kayaba H, Kamada Y,et al.An optimal condition of bronchial cell proliferation stimulated by insulin-like growth factor-I[J].Int Aroh Allergy Immunol,2000,122(Suppl 1):59-62.
  • 7Joos GF,Germonpre,Pauwels RA. Role of tachykinins in asthma[J].Allergy,2000,55(4):321-337.
  • 8Howarth PH, Beckett P, Dahl R.The effect of long-acting beta2-agonists on airway inflammation in asthmatic patients[J].Respir Mad,2000,94(Suppl F): S22-25.
  • 9Johnson M.The adrenoceptor[J].Am J Respir Crit Care Med,1998,158:S146-S153.
  • 10Taylor DR, Hancox RJ, Mcrae W.The influence of polymorphism at position 16 of theβ2 adrenoceptor on the development of tolerance to β-agonist[J].J Asthema,2000,37(8):691-700.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部